Strong growth continues at Genesis Cancer Care

The Covid-19 pandemic had limited impact on revenue growth at Genesis Cancer Care in the year ended 30 June 2020, with the Australian owned cancer treatment network reporting a 35% jump in turnover to £76.5m. The company, which was previously Cancer Partners UK, attributed the growth, which follows an increase of 40% in 2019, to…

You must be a HM Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »